Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
41.15
+1.35 (3.39%)
At close: Nov 22, 2024, 4:00 PM
43.00
+1.85 (4.50%)
After-hours: Nov 22, 2024, 4:08 PM EST
Xenon Pharmaceuticals Employees
As of December 31, 2023, Xenon Pharmaceuticals had 259 total employees, including 251 full-time and 8 part-time employees. The number of employees increased by 46 or 21.60% compared to the previous year.
Employees
259
Change (1Y)
46
Growth (1Y)
21.60%
Revenue / Employee
n/a
Profits / Employee
-$823,892
Market Cap
3.14B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
BrightSpring Health Services | 35,000 |
Neogen | 2,917 |
HUTCHMED (China) | 1,988 |
Veracyte | 815 |
Agios Pharmaceuticals | 386 |
Merus | 229 |
Dyne Therapeutics | 141 |
Edgewise Therapeutics | 88 |
XENE News
- 10 days ago - Xenon to Present at Upcoming Investor Conferences - GlobeNewsWire
- 10 days ago - Xenon Pharmaceuticals Inc. (XENE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Xenon Reports Q3 2024 Financial Results and Business Update - GlobeNewsWire
- 18 days ago - Xenon to Report Q3 2024 Financial Results on November 12, 2024 - GlobeNewsWire
- 7 weeks ago - Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference - GlobeNewsWire
- 2 months ago - Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress - GlobeNewsWire
- 3 months ago - Xenon Pharmaceuticals, Inc. (XENE) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Xenon Reports Q2 2024 Financial Results and Business Update - GlobeNewsWire